Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma.
Emerging data that show immune-regulating molecules may be ectopically expressed on human tumors suggest that novel mechanisms may induce tumor-related immune suppression, and support the use of antibodies and small molecules to target those immune-suppressive moities.